Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma

Chonglei Bi, Tae Hoon Chung, Gaofeng Huang, Jianbiao Zhou, Junli Yan, Gregory J. Ahmann, Rafael Fonseca, Wee Joo Chng

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Epigenetic alterations have emerged as an important cause of microRNA (miRNA) deregulation. In Multiple Myeloma (MM), a few tumor suppressive miRNAs silenced by DNA hypermethylation have been reported, but so far there are few systemic investigations on epigenetically silenced miRNAs. We conducted genomewide screening for tumor suppressive miRNAs epigenetically silenced in MM. Four Human MM Cell lines were treated with demethylating agent 5'azacytidine (5'aza). Consistently upregulated miRNAs include miR-155, miR-198, miR-135a*, miR-200c, miR-125a-3p, miR-188-5p, miR-483-5p, miR-663, and miR-630. Methylation array analysis revealed increased methylation at or near miRNA-associated CpG islands in MM patients. Ectopic restoration of miR-155, miR-198, miR-135a*, miR-200c, miR-663 and miR-483-5p significantly repressed MM cell proliferation, migration and colony formation. Furthermore, we derived a 33-gene signature from predicted miRNA target genes that were also upregulated in MM patients and associated with patient survival in three independent myeloma datasets. In summary, we have revealed important, epigenetically silenced tumor suppressive miRNAs by pharmacologic reversal of epigenetic silencing.

Original languageEnglish (US)
Pages (from-to)26508-26518
Number of pages11
JournalOncotarget
Volume6
Issue number28
DOIs
StatePublished - 2015

Fingerprint

Multiple Myeloma
MicroRNAs
Genome
Neoplasms
Epigenomics
Methylation
Azacitidine
CpG Islands
Genes
Cell Movement
Cell Proliferation
Cell Line
Survival
DNA

Keywords

  • Epigenetics/MicroRNA
  • Myeloma
  • Tumor suppressor

ASJC Scopus subject areas

  • Oncology

Cite this

Bi, C., Chung, T. H., Huang, G., Zhou, J., Yan, J., Ahmann, G. J., ... Chng, W. J. (2015). Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma. Oncotarget, 6(28), 26508-26518. https://doi.org/10.18632/oncotarget.4769

Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma. / Bi, Chonglei; Chung, Tae Hoon; Huang, Gaofeng; Zhou, Jianbiao; Yan, Junli; Ahmann, Gregory J.; Fonseca, Rafael; Chng, Wee Joo.

In: Oncotarget, Vol. 6, No. 28, 2015, p. 26508-26518.

Research output: Contribution to journalArticle

Bi, C, Chung, TH, Huang, G, Zhou, J, Yan, J, Ahmann, GJ, Fonseca, R & Chng, WJ 2015, 'Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma', Oncotarget, vol. 6, no. 28, pp. 26508-26518. https://doi.org/10.18632/oncotarget.4769
Bi, Chonglei ; Chung, Tae Hoon ; Huang, Gaofeng ; Zhou, Jianbiao ; Yan, Junli ; Ahmann, Gregory J. ; Fonseca, Rafael ; Chng, Wee Joo. / Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma. In: Oncotarget. 2015 ; Vol. 6, No. 28. pp. 26508-26518.
@article{c8025c1ffe9249e098a84cb79a9c960a,
title = "Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma",
abstract = "Epigenetic alterations have emerged as an important cause of microRNA (miRNA) deregulation. In Multiple Myeloma (MM), a few tumor suppressive miRNAs silenced by DNA hypermethylation have been reported, but so far there are few systemic investigations on epigenetically silenced miRNAs. We conducted genomewide screening for tumor suppressive miRNAs epigenetically silenced in MM. Four Human MM Cell lines were treated with demethylating agent 5'azacytidine (5'aza). Consistently upregulated miRNAs include miR-155, miR-198, miR-135a*, miR-200c, miR-125a-3p, miR-188-5p, miR-483-5p, miR-663, and miR-630. Methylation array analysis revealed increased methylation at or near miRNA-associated CpG islands in MM patients. Ectopic restoration of miR-155, miR-198, miR-135a*, miR-200c, miR-663 and miR-483-5p significantly repressed MM cell proliferation, migration and colony formation. Furthermore, we derived a 33-gene signature from predicted miRNA target genes that were also upregulated in MM patients and associated with patient survival in three independent myeloma datasets. In summary, we have revealed important, epigenetically silenced tumor suppressive miRNAs by pharmacologic reversal of epigenetic silencing.",
keywords = "Epigenetics/MicroRNA, Myeloma, Tumor suppressor",
author = "Chonglei Bi and Chung, {Tae Hoon} and Gaofeng Huang and Jianbiao Zhou and Junli Yan and Ahmann, {Gregory J.} and Rafael Fonseca and Chng, {Wee Joo}",
year = "2015",
doi = "10.18632/oncotarget.4769",
language = "English (US)",
volume = "6",
pages = "26508--26518",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "28",

}

TY - JOUR

T1 - Genome-wide pharmacologic unmasking identifies tumor suppressive microRNAs in multiple myeloma

AU - Bi, Chonglei

AU - Chung, Tae Hoon

AU - Huang, Gaofeng

AU - Zhou, Jianbiao

AU - Yan, Junli

AU - Ahmann, Gregory J.

AU - Fonseca, Rafael

AU - Chng, Wee Joo

PY - 2015

Y1 - 2015

N2 - Epigenetic alterations have emerged as an important cause of microRNA (miRNA) deregulation. In Multiple Myeloma (MM), a few tumor suppressive miRNAs silenced by DNA hypermethylation have been reported, but so far there are few systemic investigations on epigenetically silenced miRNAs. We conducted genomewide screening for tumor suppressive miRNAs epigenetically silenced in MM. Four Human MM Cell lines were treated with demethylating agent 5'azacytidine (5'aza). Consistently upregulated miRNAs include miR-155, miR-198, miR-135a*, miR-200c, miR-125a-3p, miR-188-5p, miR-483-5p, miR-663, and miR-630. Methylation array analysis revealed increased methylation at or near miRNA-associated CpG islands in MM patients. Ectopic restoration of miR-155, miR-198, miR-135a*, miR-200c, miR-663 and miR-483-5p significantly repressed MM cell proliferation, migration and colony formation. Furthermore, we derived a 33-gene signature from predicted miRNA target genes that were also upregulated in MM patients and associated with patient survival in three independent myeloma datasets. In summary, we have revealed important, epigenetically silenced tumor suppressive miRNAs by pharmacologic reversal of epigenetic silencing.

AB - Epigenetic alterations have emerged as an important cause of microRNA (miRNA) deregulation. In Multiple Myeloma (MM), a few tumor suppressive miRNAs silenced by DNA hypermethylation have been reported, but so far there are few systemic investigations on epigenetically silenced miRNAs. We conducted genomewide screening for tumor suppressive miRNAs epigenetically silenced in MM. Four Human MM Cell lines were treated with demethylating agent 5'azacytidine (5'aza). Consistently upregulated miRNAs include miR-155, miR-198, miR-135a*, miR-200c, miR-125a-3p, miR-188-5p, miR-483-5p, miR-663, and miR-630. Methylation array analysis revealed increased methylation at or near miRNA-associated CpG islands in MM patients. Ectopic restoration of miR-155, miR-198, miR-135a*, miR-200c, miR-663 and miR-483-5p significantly repressed MM cell proliferation, migration and colony formation. Furthermore, we derived a 33-gene signature from predicted miRNA target genes that were also upregulated in MM patients and associated with patient survival in three independent myeloma datasets. In summary, we have revealed important, epigenetically silenced tumor suppressive miRNAs by pharmacologic reversal of epigenetic silencing.

KW - Epigenetics/MicroRNA

KW - Myeloma

KW - Tumor suppressor

UR - http://www.scopus.com/inward/record.url?scp=84944462954&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944462954&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.4769

DO - 10.18632/oncotarget.4769

M3 - Article

VL - 6

SP - 26508

EP - 26518

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 28

ER -